<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">

KPC Homograft Models for PDAC Combination I/O Studies

Pancreatic ductal adenocarcinoma (PDAC) remains one of the most difficult to treat cancer types, with very few standard of care options available. The success of immune checkpoint inhibitors in other solid tumors has led to clinical trials in PDAC.